November 26, 2019
Der named AAAS Fellow
The honor recognizes Der's contributions to cancer research. His lab's recent findings on pancreatic cancer have led to clinical studies of a new treatment.
Yearly Archives: 2019
November 25, 2019
ATP Tour: Isner Launches The Isner Family Foundation
November 23, 2019
Fox Sports Carolinas: Hockey Fights Cancer interview with Michael Emanuele, PhD
November 21, 2019
WTVD: UNC doctors don purple for World Pancreatic Cancer Day, speak on new research
November 21, 2019
Pancreatic cancer tumor classification could optimize treatment choices
In Clinical Cancer Research, a journal of the American Association for Cancer Research, Jen Jen Yeh, MD, and Naim Rashid, PhD, reported findings for how two subtypes of pancreatic cancer respond to treatments differently. Importantly, they found that one subtype of the disease showed poor responses to common therapies and also had worse survival outcomes.
November 19, 2019
Shea publishes five-year follow-up data on pretransplant induction strategy for mantle cell lymphoma
Thomas C. Shea, MD, professor emeritus, co-authored a study published in the journal Blood Advances. The study aimed to determine the optimal induction regimen for patient’s mantle cell lymphoma (MCL) receiving an autologous stem cell transplant. There is a standard option for the initial management of transplant-eligible mantle cell lymphoma. The approach is an aggressive …
November 19, 2019
Wood coauthors column on the value of collecting, assessing patient information outside the clinic via sensors
UNC Lineberger’s William Wood, MD, MPH, associate professor of medicine at the UNC School of Medicine, co-authored an opinion column published in STAT, an online medical and life sciences news site. The column describes the value of collecting patient information outside of the clinic. That data is captured by a sensor used outside of the clinic …
November 18, 2019
Researchers find KRAS gene mutation differences have implications for pancreatic cancer treatment
The KRAS gene is commonly mutated in cancer. In the journal Cancer Discovery, researchers led by Channing Der, PhD, and Aaron Hobbs, PhD, reported details of the role of the KRAS G12R mutation in pancreatic cancer, and therapeutic strategies that might work for this mutation type. By studying unique differences in DNA mutations within the same gene, researchers are working to uncover the mutation-specific mechanisms that drive cancerous growth.
November 18, 2019
Mirlekar named recipient of Society for Immunotherapy of Cancer’s 2019 Young Investigator Award
The Society for Immunotherapy of Cancer honored Rahul Mirlekar, PhD, a postdoctoral research associate at UNC Lineberger, as a recipient of its 2019 Young Investigator Award. The society honored Mirlekar at its 34th Annual Meeting, held Nov. 6-10 in National Harbor, Maryland. The meeting was expected to attract more than 4,000 researchers, clinicians, pharmacists and …
November 14, 2019